한글목차

세계 줄기세포 치료 시장은 2025년에는 186억 1,000만 달러, 2032년에는 783억 9,000만 달러에 이르고, 2025-2032년 연평균 성장률(CAGR) 22.8%로 성장할 것으로 예측됩니다.

그림. 줄기세포 치료 시장 점유율(%), 2025년 지역별

줄기세포 치료는 줄기세포와 그 유도체를 이용하여 손상된 조직이나 세포를 수복 및 재생하는 재생의료에서 유망한 신분야입니다. 줄기세포는 생명의 매우 이른 단계부터 모든 인간에게 존재합니다. 줄기 세포는 세포 분열에 의해 자기를 재생하고 다양한 유형의 특수 세포로 분화하는 독특한 능력을 가지고 있습니다. 이 세포들은 이식과 조직 재생을 통해 많은 난치병을 치료할 수 있는 큰 잠재력을 가지고 있습니다. 줄기세포 연구는 암, 당뇨병, 심장병, 변형성 관절증, 신경질환 등 다양한 질병을 치료할 수 있는 치료법을 개발하기 위해 줄기세포의 자연적인 힘을 이용하는 것을 목적으로 하고 있습니다.

시장 역학 :

세계 줄기세포 치료 시장의 성장은 만성 질환 증가, 줄기 세포 치료 성공률 상승, 재생 의료의 급속한 진보, 줄기 세포 치료 연구개발 투자 증가, 새로운 치료법 승인 등 요인에 의해 견인되고 있습니다. 그러나 줄기세포의 연구개발과 치료에의 응용에 드는 높은 비용과 배아 줄기세포와 관련된 윤리적인 문제는 시장의 성장을 방해할 수 있습니다. 새로운 줄기세포 소스 개발, 줄기세포를 효율적으로 생산하기 위한 첨단기술 플랫폼 개발, 맞춤형 줄기세포 요법을 보다 신속하게 개발하기 위한 인공지능의 응용은 향후 시장 성장 기회를 제공할 수 있습니다. 저렴한 줄기세포 요법을 세계적으로 개발하고 줄기세포 은행의 효율적인 기술을 개발하면 충족되지 않은 요구를 충족시키고 시장을 확대할 수 있습니다.

본 조사의 주요 특징

• 본 보고서에서는 세계 줄기세포 치료 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모(10억 달러)와 연간 평균 성장률(CAGR%)을 제공합니다.
• 또한 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
• 이 문서에서는 줄기 세포 치료 세계 시장에서 주요 기업을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개 변수를 기반으로 프로파일링합니다.
• 주요 기업 : Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co.Ltd., Pharmicell Co., Inc., Stemedica Cell Technologies, Inc., Magellan, Medipost Co. Ltd., Athersys Inc., Biorestorative Therapies Inc., Brainstorm Cell Limited., ViaCyte Inc., Celular Biomedicine Group, ANTEROGEN.CO, LTD., NuVasive Inc., RTI Surgical, AlloSource
• 이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
• 세계 줄기세포 치료 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자들에 대응하고 있습니다.
• 이해관계자들은 세계 줄기세포 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 주요 발전
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금 조달 및 투자
• PEST 분석
• Porter's Five Forces 분석

제4장 세계 줄기세포 치료 시장 - 코로나바이러스(COVID-19) 유행의 영향

• 전체적인 영향
• 정부의 대처
• COVID-19에 의한 시장에 대한 영향

제5장 세계의 줄기세포 치료 시장, 세포원별, 2020년-2032년,(10억 달러)

• 성체 줄기세포
• 유도 다능성 줄기세포
• 배아 줄기 세포
• 기타

제6장 세계의 줄기세포 치료 시장, 용도별, 2020년-2032년,(10억 달러)

• 근골격 장애
• 상처와 부상
• 암
• 자가면역질환
• 기타

제7장 세계의 줄기세포 치료 시장, 최종 사용자별, 2020년-2032년(10억 달러)

• 병원
• 세포 뱅크
• 학술연구기관

제8장 세계의 줄기세포 치료 시장, 지역별, 2020년-2032년,(10억 달러)

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 프로파일
  • Osiris Therapeutics, Inc.
  • Kolon TissueGene, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Anterogen Co. Ltd.
  • Pharmicell Co., Inc.
  • Stemedica Cell Technologies, Inc.
  • Magellan
  • Medipost Co., Ltd
  • Athersys Inc.
  • Biorestorative Therapies Inc.
  • Brainstorm Cell Limited.
  • ViaCyte Inc.
  • Cellular Biomedicine Group
  • ANTEROGEN. CO, LTD.
  • NuVasive Inc.
  • RTI Surgical
  • AlloSource

제10장 분석가 추천

• 기회
• 애널리스트의 견해
• Coherent Opportunity Map

제11장 참고문헌과 조사방법

• 참고문헌
• 조사 방법

영문목차

Global Stem Cell Therapy Market is estimated to be valued at USD 18.61 Bn in 2025 and is expected to reach USD 78.39 Bn by 2032, growing at a compound annual growth rate (CAGR) of 22.8% from 2025 to 2032.

Figure. Stem Cell Therapy Market Share (%), By Region 2025

Stem cell therapy is a promising and emerging field in regenerative medicine that involves the use of stem cells and their derivatives to repair or regenerate damaged tissues and cells. Stem cells are found in all human beings from a very early stage of life. These have the unique ability to renew themselves through cell division and differentiate into a diverse range of specialized cell types. These cells hold great potential to treat many incurable diseases through transplantation or tissue regeneration. Stem cell research aims to harness the natural powers of stem cells to develop therapies that can cure various diseases like cancer, diabetes, heart disease, osteoarthritis and neurological disorders.

Market Dynamics:

Global stem cell therapy market growth is driven by factors such as rising prevalence of chronic diseases, increasing success rates of stem cell therapies, rapid advancements in regenerative medicine, growing investments for research and development in stem cell therapies and approval of new therapies. However, high costs involved in stem cell research & development and therapeutic applications along with ethical issues related to embryonic stem cells can hamper the market growth. Emergence of new stem cell sources, development of advanced technology platforms for efficient production of stem cells, and application of artificial intelligence for faster development of customized stem cell therapies can offer opportunities for the market growth in the future. Providing affordable stem cell therapies globally and developing efficient techniques for stem cell banking can help to address unmet needs and expand the market reach.

Key Features of the Study:

• This report provides an in-depth analysis of the global stem cell therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global stem cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., Stemedica Cell Technologies, Inc., Magellan, Medipost Co., Ltd, Athersys Inc., Biorestorative Therapies Inc., Brainstorm Cell Limited., ViaCyte Inc., Cellular Biomedicine Group, ANTEROGEN. C.O., LTD., NuVasive Inc., RTI Surgical, AlloSource.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global stem cell therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell therapy market.

Detailed Segmentation-

• By Cell Source:
  • Adult Stem Cells
  • Induced Pluripotent Stem Cells
  • Embryonic Stem Cells
  • Others
• By Application:
  • Musculoskeletal Disorders
  • Wounds and Injuries
  • Cancer
  • Autoimmune Disorders
  • Others
• By End User:
  • Hospitals
  • Cell Banks
  • Academic and Research Institutes
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Osiris Therapeutics, Inc.
  • Kolon TissueGene, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Anterogen Co. Ltd.
  • Pharmicell Co., Inc.
  • Stemedica Cell Technologies, Inc.
  • Magellan
  • Medipost Co., Ltd
  • Athersys Inc.
  • Biorestorative Therapies Inc.
  • Brainstorm Cell Limited.
  • ViaCyte Inc.
  • Cellular Biomedicine Group
  • C.O., LTD.
  • NuVasive Inc.
  • RTI Surgical
  • AlloSource

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Cell Source
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Stem Cell Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Stem Cell Therapy Market, By Cell Source, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Adult Stem Cells
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Induced Pluripotent Stem Cells
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Embryonic Stem Cells
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Stem Cell Therapy Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Musculoskeletal Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Wounds and Injuries
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Autoimmune Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Stem Cell Therapy Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cell Banks
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Stem Cell Therapy Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Osiris Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Kolon TissueGene, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • JCR Pharmaceuticals Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Anterogen Co. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pharmicell Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Stemedica Cell Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Magellan
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medipost Co., Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Athersys Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biorestorative Therapies Inc.
  • Brainstorm Cell Limited.
  • ViaCyte Inc.
  • Cellular Biomedicine Group
  • ANTEROGEN. C.O., LTD.
  • NuVasive Inc.
  • RTI Surgical
  • AlloSource

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact